Preliminary experiments point out conolidine may inhibit certain ion channels, lowering neuronal excitability and restricting discomfort signals. This mechanism is particularly pertinent in neuropathic suffering, in which irregular signaling leads to persistent discomfort. On top of that, conolidine appears to impact G protein-coupled receptor (GPC